小剂量奥氮平可作为增效剂用于治疗强迫症。
Small dose of Olanzapine can be effectively used as a potentiator for obsessive compulsive disorder.
本发明涉及一种稳定的包含奥氮平的药物制剂。
This invention relates to a stable pharmaceutical formulation containing olanzapine.
目的探讨奥氮平治疗脑外伤后急性谵妄综合征的疗效。
Objective To study therapeutic efficacy of olanzapine for acute delirium after brain trauma.
结论奥氮平是一种有效的抗躁狂药物,不良反应少且轻。
Conclusion Olanzapine is an effective anti-manic and its adverse reactions are significantly fewer than the clozapine's.
目的:比较奥氮平与氯氮平治疗躁狂症的疗效与副反应。
Objective: To compare the therapeutic effect and side effects between olanzapine and clozapine in the treatment of mania.
目的:了解奥氮平对器质性精神障碍的治疗作用及安全性。
Objective: To comprehend the effect and safety of olanzapine in treating organic mental disorder.
目的:探讨不同剂量的奥氮平治疗边缘性人格障碍患者的疗效。
AIMS: To evaluate treatment with variably dosed olanzapine in individuals with borderline personality disorder.
目的探讨西酞普兰合并奥氮平对伴有躯体症状抑郁症的治疗效果。
Objective to investigate the efficacy of citalopram combined with olanzapine in the treatment of depression with somatic symptoms.
目的:探讨奥氮平对无血清诱导PC 12细胞凋亡的保护作用及其机制。
Objective: to investigate the possible protective effects and related mechanisms of olanzapine on PC12 cells, apoptosis induced by serum-free culture was observed.
去年,奥氮平的长效配方在欧洲得到核准,其品牌名为Zypadhera。
The long-acting formulation of olanzapine was approved in Europe last year under the brand name Zypadhera.
目的:探讨奥氮平对患者认知功能的影响及认知功能与阳性和阴性症状的关系。
Objectivre: Discusses the Austria nitrogen to put down to the patient cognition function influence and the cognition function and masculine and the negative symptom relations.
并且奥氮平对记忆功能、执行功能的改善与阳性症状、阴性症状的下降呈显著正相关。
There was greatly positive relationship between the increased cognitive function and the decreased psychiatric symptoms.
食用奥氮平的大鼠没有出现体重或食物摄入量的增加,但储存在腹腔的脂肪比例明显增高。
The rats consuming olanzapine did not gain weight or increase their food intake; however, the proportion of fat stored in their abdominal cavity was notably higher.
在奥氮平组的基础上,利培酮组和喹硫平组增加单位效果所需成本比较,利培酮组小于喹硫平组。
Based on the olanzapine group, the unit effectiveness cost in amount increase was smaller in the risperdal group than in the quetiapine group.
目的:研究抗精神失常药万拉法辛和奥氮平对撤掉血清诱发PC 12细胞损伤的神经保护作用。
Objective to study the protective effects of antipsychotic drugs Venlafaxine and Olanzapine on pheochromocytoma (PC12) cells after serum withdrawal.
结论奥氮平能有效控制脑外伤后急性谵妄综合征,同时不影响病人意识的观察,起效快、安全性高。
Conclusion Olanzapine can effectively control acute delirium after brain trauma with a high efficiency and safety, and has no affect on the observation of patients.
结论对首次服用奥氮平治疗的患者及早采用饮食与运动量化管理,可有效控制体质量的增加,预防肥胖发生。
Conclusion Quantitative management of diet and exercises can reduce weight gain and prevent obesity in patients initially administered with Olanzapine.
结果小剂量奥氮平治疗有效率100.0%,显效率66.3%,副反应量表、心电图、肝肾功能前后无差异。
RESULTS After 1 week treatment, total efficiency was 100.0%, the efficiency was 66.3%, but there were no significant differences in TESS , ECG and liver renal function.
结论:奥氮平在有效剂量范围内对大鼠的循环系统和呼吸系统均有一定的影响,对小鼠的神经系统有明显的抑制作用。
Conclusion: Effective doses of olanzapine had effects on circulatory and respiratory systems in rats and inhibitory effects on nervous system in mice.
方法:对服用氯丙嗪、利培酮、奥氮平、氯氮平的精神分裂症患者,进行疗效、不良反应、生活质量和治疗费用进行调查。
METHODS: To investigate the efficiency, adverse reactions, life quality and treatment costs of schizophrenic patients taking chlorderazin, olanzapine risperidone and clozapine.
结果:利培酮组、奥氮平组和奎硫平组的显效率分别为44%、88%、76%,奥氮平组和奎硫平组的疗效要好于利培酮组。
Results:The response rates of risperidone group 44%, olanzapine group 88%, and seroquel group 76%, olanzapine group and seroquel group demonstrated higher efficacy than risperidone group.
方法用奥氮平治疗首发精神分裂症32例,疗程8周;用简明精神病评定量表(BPRS)和副反应量表(TESS)评定疗效及副反应。
Method: 32 patients with first episode schizophrenia were treated with olanzapine for 8 weeks, and assessed with BPRS and TESS for the efficacy and safety.
结果(1 )奥氮平组、氟哌啶醇组及对照组治疗后临床严重度总体印象量表SI分值降低,差异具有显著性(P< 0 .0 1 ) ;
Results (1)CGI SI scores of olanzapine treatment group, haloperidol treatment group and a control group were reduced significantly after treatment ( P< 0.01).
在一次采访中,tyrer博士表示,没有理由相信任何其他抗精神病药例如礼来公司奥氮平或阿斯利康公司的思瑞康等用于治疗躁狂将更为有效。
In an interview, Dr. Tyrer said there was no reason to believe that any other antipsychotic drug used for aggression, like Zyprexa from Eli Lilly or Seroquel from AstraZeneca, would be more effective.
在一次采访中,tyrer博士表示,没有理由相信任何其他抗精神病药例如礼来公司奥氮平或阿斯利康公司的思瑞康等用于治疗躁狂将更为有效。
In an interview, Dr. Tyrer said there was no reason to believe that any other antipsychotic drug used for aggression, like Zyprexa from Eli Lilly or Seroquel from AstraZeneca, would be more effective.
应用推荐